Veracyte Inc (VCYT)

Current ratio

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Total current assets US$ in thousands 414,681 383,152 372,267 356,854 321,106 290,418 285,621 271,163 259,480 251,503 248,636 238,516 235,045 238,483 243,102 229,308 371,346 362,092 375,679 370,315
Total current liabilities US$ in thousands 76,433 75,125 78,633 70,313 72,339 58,052 61,241 57,260 58,151 55,993 62,614 58,352 59,345 62,543 64,151 50,037 36,105 32,709 16,781 13,919
Current ratio 5.43 5.10 4.73 5.08 4.44 5.00 4.66 4.74 4.46 4.49 3.97 4.09 3.96 3.81 3.79 4.58 10.29 11.07 22.39 26.61

June 30, 2025 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $414,681K ÷ $76,433K
= 5.43

The current ratio of Veracyte Inc. has demonstrated notable fluctuations over the specified period, reflecting changing liquidity positions. As of September 30, 2020, the current ratio was remarkably high at 26.61, indicating an exceptionally strong liquidity cushion relative to current liabilities. This elevated ratio persisted into 2020, gradually declining to 22.39 by December 31, 2020. A significant reduction occurred during the first quarter of 2021, with the ratio decreasing to 11.07, and continued to diminish through the second quarter of 2021, reaching 10.29.

Subsequently, there was a sharp decline noted by the end of September 2021, where the ratio fell to 4.58, signaling a material reduction in liquidity cushioning. The downward trend persisted into 2022, with ratios of 3.79 at year-end December 2021 and a modest uptick to approximately 3.81 and 3.96 in the first and second quarters of 2022, respectively. Throughout 2022 and into 2023, the current ratio remained relatively stable, fluctuating within a narrow range—from 4.09 at September 30, 2022, to 4.66 as of December 31, 2023—highlighting a period of stabilization in liquidity levels.

Beginning in 2024, the ratio experienced modest increases, reaching 5.00 on March 31, 2024, and slightly declining to 4.44 in June 2024 before rebounding to 5.08 as of September 30, 2024. The trend continued with ratios of 4.73 at December 31, 2024, and further increases to 5.10 in the first quarter of 2025 and 5.43 in the second quarter of 2025.

Throughout the entire timeframe, the relatively high current ratios suggest that Veracyte Inc. maintained a generally strong liquidity position. However, the drastic decline observed from over 26 in September 2020 to just above 4 by September 2021 indicates a significant reduction in liquidity buffer, likely driven by factors such as increased current liabilities, decreased current assets, or both during that period. Since then, the ratios indicate a pattern of stabilization and modest growth, suggesting improved or restored liquidity positions in the more recent periods, albeit at levels markedly lower than the initial 2020 figures.